Former England cricketer Kevin Pietersen has suggested that the Australian government issue an apology to Novak Djokovic after the tennis great was not allowed to enter the Down Under country to participate in the Australian Open at the peak of the coronavirus pandemic in 2022.

After AstraZeneca row, Kevin Pietersen says Australian govt should apologise to Novak Djokovic

Europe's drug regulator on Friday identified another very rare blood condition as a potential side effect of AstraZeneca's COVID-19 vaccine and said it was looking into cases of heart inflammation after inoculation with all coronavirus shots.

EU adds another rare blood condition as side effect of AstraZeneca shot

Canada's health department said on Sunday the 1.5 million doses of the Astrazeneca Plc COVID-19 vaccine imported from Emergent BioSolutions' Baltimore facility were safe and met quality specifications.

Canada says AstraZeneca COVID-19 vaccines from suspended US plant are safe

A total of 168 people have suffered rare blood clots after taking the AstraZeneca coronavirus vaccine in Britain, and 32 have died, the UK's medicines regulator said Thursday.

UK reports 32 deaths from clots after AstraZeneca jabs

The AstraZeneca and Johnson & Johnson vaccines have come under suspicion of causing very rare but serious blood clots in a handful of cases among the millions vaccinated in the drive to bring the Covid-19 pandemic under control.

Blood clots are latest curse of coronavirus vaccines. All you need to know

Australia said on Friday it had ordered more alternatives for the AstraZeneca vaccine, setting back its vaccination rollout, and Hong Kong delayed deliveries of the shot amid concern about a possible very small risk of rare blood clots.

Australia orders more alternatives for AstraZeneca vaccine setting back its rollout

Europe’s drug regulator has denied establishing a causal connection between the AstraZeneca coronavirus vaccine and the formation of blood clots. A little after a senior official claimed that the European Medicines Agency (EMA) had already established a link between the AstraZeneca-Oxford jab and a rare blood clotting syndrome, the regulator has backtracked on the official’s statement and has said that it has “not yet reached a conclusion and the review is currently ongoing”.

EU drug regulator says it hasn't found causal link between AstraZeneca and blood clots

Britain should not give Oxford/AstraZeneca's COVID-19 vaccine to under 30s where possible, Britain's Joint Committee on Vaccination and Immunisation (JCVI) said on Wednesday, due to a very rare side effect of blood clots in the brain.

Britain advises alternative to Oxford/AstraZeneca COVID-19 vaccine for under-30s

The European Medicines Agency said on Wednesday that 'benefit-risk remains positive' for AstraZeneca coronavirus vaccine. “One plausible explanation for the combination of blood clots and low blood platelets is an immune response, leading to a condition similar to one seen sometimes in patients treated with heparin,” the European Medicines Agency (EMA) said.

EMA says 'benefit-risk remains positive' for AstraZeneca jab

Canadian health officials said they would stop offering AstraZeneca's COVID-19 vaccine to people aged under 55 and require a new analysis of the shot's benefits and risks based on age and gender.

Canada to pause AstraZeneca COVID-19 vaccine use for those under 55

India has said that it is going ahead with administring the AstraZeneca COVID-19 vaccine and will continue to roll out the shot in its huge immunisation programme "with full vigour".

India: AstraZeneca vaccinations will go on with full vigour